Vertex Pharmaceuticals Probability of Target Price Finishing Above 223.07

<div class='logoBackup' style='background:#754DEB;color: white;font-size:3em;;'>VRT</div>
VRTX -- USA Stock  

Earning Report: February 4, 2020  

Vertex Pharmaceuticals probability of target price tool provides mechanism to make assumptions about upside and downside potential of Vertex Pharmaceuticals Incorpor performance during a given time horizon utilizing its historical volatility. Please specify Vertex Pharmaceuticals time horizon, a valid symbol (red box) and a target price (blue box) you would like Vertex Pharmaceuticals odds to be computed. Also please take a look at Vertex Pharmaceuticals Backtesting, Vertex Pharmaceuticals Valuation, Vertex Pharmaceuticals Correlation, Vertex Pharmaceuticals Hype Analysis, Vertex Pharmaceuticals Volatility, Vertex Pharmaceuticals History as well as Vertex Pharmaceuticals Performance.
Horizon     30 Days    Login   to change
Refresh Odds

Vertex Pharmaceuticals Target Price Odds to finish below 223.07

Current PriceHorizonTarget PriceOdds to drop to $ 223.07  or more in 30 days
 234.15 30 days 223.07 
about 76.66
Based on normal probability distribution, the odds of Vertex Pharmaceuticals to drop to $ 223.07  or more in 30 days from now is about 76.66 (This Vertex Pharmaceuticals Incorpor probability density function shows the probability of Vertex Pharmaceuticals Stock to fall within a particular range of prices over 30 days) . Probability of Vertex Pharmaceuticals price to stay between $ 223.07  and its current price of $234.15 at the end of the 30-day period is about 15.97 .
Given the investment horizon of 30 days, Vertex Pharmaceuticals has beta of 0.581 . This entails as returns on market go up, Vertex Pharmaceuticals average returns are expected to increase less than the benchmark. However during bear market, the loss on holding Vertex Pharmaceuticals Incorpor will be expected to be much smaller as well. Additionally The company has an alpha of 0.3629 implying that it can potentially generate 0.3629% excess return over DOW after adjusting for the inherited market risk (beta).
 Vertex Pharmaceuticals Price Density 
Alpha over DOW
Beta against DOW=0.58
Overall volatility
Information ratio =0.23

Vertex Pharmaceuticals Alerts and Suggestions

Over 99.0% of the company outstanding shares are owned by institutional investors
Latest headline from MacroaxisInsider: Exercise or conversion by Riley Wayne Joseph of 10000 shares of Vertex Pharmaceuticals subject to Rule 16b-3

Vertex PharmaceuticalsPrice Density Drivers

Shares Percent Shares Out1.41%
Short Percent Of Float1.57%
Float Shares256.82M
Shares Short Prior Month4M
Average Daily Volume Last 10 Day1.28M
Average Daily Volume In Three Month1.34M
Date Short InterestDecember 13, 2019